Stay updated on Ferumoxytol MRI in Glioblastoma Response Clinical Trial
Sign up to get notified when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.

Latest updates to the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check44 days agoChange DetectedThe page has undergone significant updates, including the addition of a new study identifier and collaborators, while extensive details about the study's objectives and procedures have been removed. The principal investigator's name has also been added.SummaryDifference53%
- Check51 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check59 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check95 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Ferumoxytol MRI in Glioblastoma Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.